Schroders Capital Global Innovation Trust plc - INOV
Schroders Capital Global Innovation Trust plc - INOV specializes in investments in startups, midsize, middle market and large stage, early stage and mature stage investments. The fund primarily invests in the healthcare, financials, industrials, technology, consumer goods, telecommunications, basic materials, and biotechnology sector. It primarily invests in companies incorporated in the United K… Read more
Schroders Capital Global Innovation Trust plc - INOV (INOV) - Total Liabilities
Latest total liabilities as of December 2024: GBX898.00K GBX
Based on the latest financial reports, Schroders Capital Global Innovation Trust plc - INOV (INOV) has total liabilities worth GBX898.00K GBX as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Schroders Capital Global Innovation Trust plc - INOV - Total Liabilities Trend (2021–2024)
This chart illustrates how Schroders Capital Global Innovation Trust plc - INOV's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Schroders Capital Global Innovation Trust plc - INOV Competitors by Total Liabilities
The table below lists competitors of Schroders Capital Global Innovation Trust plc - INOV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aerius International Inc
PINK:AERS
|
USA | $66.96K |
|
Cgrowth Capital Inc
PINK:CGRA
|
USA | $83.39 Million |
|
Tian'an Pharmaceutical Co Ltd
PINK:TNPH
|
USA | $91.36K |
Liability Composition Analysis (2021–2024)
This chart breaks down Schroders Capital Global Innovation Trust plc - INOV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Schroders Capital Global Innovation Trust plc - INOV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Schroders Capital Global Innovation Trust plc - INOV (2021–2024)
The table below shows the annual total liabilities of Schroders Capital Global Innovation Trust plc - INOV from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX898.00K | -38.20% |
| 2023-12-31 | GBX1.45 Million | +68.17% |
| 2022-12-31 | GBX864.00K | -96.29% |
| 2021-12-31 | GBX23.28 Million | -- |